157 related articles for article (PubMed ID: 1503454)
1. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone.
Figueiredo AM; Connor JD; Severin A; Vaz Pato MV; Tomasz A
Antimicrob Agents Chemother; 1992 Apr; 36(4):886-9. PubMed ID: 1503454
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Bell SM; Gatus BJ; Pham JN
Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
[No Abstract] [Full Text] [Related]
3. Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniae.
Albrecht WE; Papasian CJ; Bamberger DM; Fiorella R; Riddell SW
J Clin Microbiol; 1997 Apr; 35(4):985-7. PubMed ID: 9157169
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
5. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Thornsberry C; Burton PH; Vanderhoof BH
Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
[TBL] [Abstract][Full Text] [Related]
6. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
7. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
8. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
Karlowsky JA; Jones ME; Draghi DC; Sahm DF
Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
[TBL] [Abstract][Full Text] [Related]
9. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
10. Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
Barry AL; Fuchs PC
J Clin Microbiol; 1996 Oct; 34(10):2609-12. PubMed ID: 8880533
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
Skulnick M; Small GW; Lo P; Patel MP; Porter CR; Low DE; Matsumura S; Mazzulli T
J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
[TBL] [Abstract][Full Text] [Related]
12. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Williams-Bouyer N; Hernandez A; Reisner BS
J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
[TBL] [Abstract][Full Text] [Related]
13. Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae.
Smith AM; Feldman C; Massidda O; McCarthy K; Ndiweni D; Klugman KP
Antimicrob Agents Chemother; 2005 May; 49(5):2002-7. PubMed ID: 15855525
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
17. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
Haas DW; Stratton CW; Griffin JP; Weeks L; Alls SC
Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in central Taiwan.
Liu PY; Hu BS; Fung CP; Lau YJ; Shi ZY; Lin YH
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):511-5. PubMed ID: 9764388
[TBL] [Abstract][Full Text] [Related]
19. Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Karlowsky JA; Jones ME
J Antimicrob Chemother; 2003 Feb; 51(2):467-8. PubMed ID: 12562727
[No Abstract] [Full Text] [Related]
20. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
